ライフサイエンスコーパス: gastrointestinal

1 There were no differences in late grade >= 3 gastrointestinal (2% v 3%, P = .33) or genitourinary tox

2 Renal (39.8%), gastrointestinal (24.1%), bone (22.9%), and psychiatric

3 y B cells (60.3%), and respiratory (83%) and gastrointestinal (28.6%) infections, thus characterizing

4 By employing gastrointestinal 3D organoids, we detect that ERK3 prote

5 nal content and release hormones to regulate gastrointestinal activity, systemic metabolism, and food

6 sepsis is a serious concern in patients with gastrointestinal acute radiation syndrome (GIARS).

7 aglutide group than in the placebo group had gastrointestinal adverse events (81 of 125 [64.8%] vs. 4

8 In patients who had a gastrointestinal anastomosis, NSAIDs were not associated

9 enced the genomes of 110 VREfm isolates from gastrointestinal and blood cultures of 24 pediatric pati

10 variants that arose over time in subsequent gastrointestinal and blood isolates from each patient an

11 xperts from 5 surgical societies (Society of Gastrointestinal and Endoscopic Surgeons, Americas Hepat

12 Current Society of Gastrointestinal and Endoscopic Surgery guidelines recom

13 ong individuals presenting with a variety of gastrointestinal and even nongastrointestinal symptoms a

14 e effects of cannabis and its derivatives on gastrointestinal and hepatic function in health and dise

15 rogenitor cells produce multiple pancreatic, gastrointestinal and hypothalamic peptides in addition t

16 tly in the second phase of treatment without gastrointestinal and joint symptoms.

17 c brain injury (TBI) is often accompanied by gastrointestinal and metabolic disruptions.

18 Gastrointestinal and muscular complications of cystinosi

19 ffective, and opioids increased the risk for gastrointestinal and neurologic harms (all moderate-cert

20 ption, maturation, and dietary modulation of gastrointestinal and nutritional fungal communities and

21 utcomes and chronic diseases such as cancer, gastrointestinal and psychiatric diseases and disorders.

22 rients), gut microbiota and mucous barriers (gastrointestinal and respiratory tract) and their import

23 aracterized by a combination of respiratory, gastrointestinal, and constitutional symptoms.

24 ters tailored to cardiovascular, urological, gastrointestinal, and neurovascular applications.

25 to 5 years and were highest for respiratory, gastrointestinal, and viral infections.

26 rmed for ascites (159 of 334 patients, 48%), gastrointestinal bleeding (127 of 334 patients, 38%), or

27 /10ib mice, as well as significantly reduced gastrointestinal bleeding and anemia in inducible ALK1-d

28 However, the 10-year risk of gastrointestinal bleeding did not differ significantly b

29 ular carcinoma, liver-related mortality, and gastrointestinal bleeding in persons with chronic hepati

30 prescribed apixaban also had a lower rate of gastrointestinal bleeding or intracranial hemorrhage (12

31 In patients with acute upper gastrointestinal bleeding who were at high risk for furt

32 l bleeding or recent acute bleeding (such as gastrointestinal bleeding), patients with acute ischaemi

33 irin, without a significantly higher risk of gastrointestinal bleeding.

34 Timing of endoscopy for acute upper gastrointestinal bleeding.

35 The completeness of the Dutch Upper gastrointestinal Cancer Audit was estimated at 99.8%.

36 Data was acquired from the Dutch Upper Gastrointestinal Cancer Audit.

37 Unexpectedly, we show here that, in gastrointestinal cancer cells, glucose activates AMPK to

38 Ampullary adenocarcinoma is a rare gastrointestinal cancer in which WNT signalling dysregul

39 serially obtained from a cohort of advanced gastrointestinal cancer patients enrolled in a trial wit

40 e association of fish consumption with upper gastrointestinal cancer risk, but the associations with

41 onsumption, IBS diagnosis, family history of gastrointestinal cancer, smoking status, previous negati

42 struct to vaccinate patients with metastatic gastrointestinal cancer.RESULTSThe vaccine was safe and

43 NAT for gastrointestinal cancers results in overall lower LN yie

44 ne/threonine kinase that is overexpressed in gastrointestinal cancers, including esophageal, gastric,

45 gnaling is aberrantly activated in different gastrointestinal cancers, including hepatocellular carci

46 ry disease associated with increased risk of gastrointestinal cancers.

47 et selection for resistance in transmissible gastrointestinal (carriage) populations of E. faecium.

48 , we have demonstrated a significant role of gastrointestinal Chlamydia in promoting pathology in the

49 intestinal surface could potentially target gastrointestinal colonization.

50 tion have included fever, malaise, anorexia, gastrointestinal complaints, thrombocytopenia, neutropen

51 This cohort study compares the incidence of gastrointestinal complications (transaminitis, ileus, Og

52 Lipopeptide survived the gastrointestinal conditions, induced humoral immune resp

53 ome measures included allergic reactions (ie gastrointestinal, dermatological, and respiratory sympto

54 bioaccessibility with an in vitro simulated gastrointestinal digestion according to the INFOGEST(R)

55 The strawberries were subjected to in vitro gastrointestinal digestion and colonic fermentation to e

56 Taking the effects of cooking and gastrointestinal digestion into account gives a more rea

57 valuated at storage time and during in vitro gastrointestinal digestion of all beverages.

58 re measured at different phases of simulated gastrointestinal digestion of banana treated with 1000 p

59 ssibility of phytochemicals during simulated gastrointestinal digestion of cell-based carriers.

60 iscuit slightly decreased viability, whereas gastrointestinal digestion of such melanoidins softened

61 fied the effects of processing and simulated gastrointestinal digestion on polyphenols content.

62 Protein digestibility assessed by in vitro gastrointestinal digestion showed a 4.2-fold higher hydr

63 , spinach, kale and rocket after a simulated gastrointestinal digestion using a newly optimised SEC-I

64 dogenous polyphenols in GSP during simulated gastrointestinal digestion was similar to the release pr

65 evolution of oleuropein (OE) during in vitro gastrointestinal digestion, its bioaccessibility and pot

66 ceptible to degradation during the simulated gastrointestinal digestion.

67 3G, whereas D3G completely disappeared after gastrointestinal digestion.

68 n influencing the release of curcumin during gastrointestinal digestion.

69 ry, their in vitro biological activities and gastrointestinal digestive stability and bioaccessibilit

70 tudy population included participants in the Gastrointestinal Disease and Endoscopy Registry (GIDER),

71 closely related to ST313 variants that cause gastrointestinal disease in the United Kingdom and Brazi

72 Gastrointestinal disease is associated with a more benig

73 enrolled across 9 Consortium of Eosinophilic Gastrointestinal Disease Researchers-associated sites.

74 Crohn's disease (CD) is a chronic gastrointestinal disease resulting from the dysfunctiona

75 o inflammatory bowel disease or eosinophilic gastrointestinal disease showed the least benefit and in

76 e genus Shigella cause shigellosis, a severe gastrointestinal disease that is a major cause of diarrh

77 tis, while more subjects without significant gastrointestinal disease were anemic on presentation.

78 Eosinophilic gastrointestinal diseases (EGIDs) are rare diseases of t

79 of waterborne diseases, including diarrhea, gastrointestinal diseases, and systemic illnesses.

80 altered iron distribution occur in multiple gastrointestinal diseases, but the importance and regula

81 ity of new research approaches investigating gastrointestinal diseases.

82 8 h of admission in a group of patients with gastrointestinal diseases.

83 ritable bowel syndrome (IBS) is a functional gastrointestinal disorder associated with intestinal dys

84 Irritable bowel syndrome is a functional gastrointestinal disorder with symptoms including abdomi

85 ople will be labelled as having a functional gastrointestinal disorder, such as irritable bowel syndr

86 acid reflux into the esophagus, is a common gastrointestinal disorder.

87 ] of 240 patients in the busulfan group) and gastrointestinal disorders (24 [11%] patients vs 39 [16%

88 Patients with functional gastrointestinal disorders can feel stigmatised, and oft

89 The pathophysiology of functional gastrointestinal disorders is complex, but involves bidi

90 lpha3 and evaluate its associations with the gastrointestinal disorders UC, CD and CRC, in comparison

91 d host defence, and is often dysregulated in gastrointestinal disorders(1).

92 omes colonized, which-in some cases-leads to gastrointestinal disorders(1-4).

93 remodeling is a hallmark of the pathology of gastrointestinal disorders.

94 therefore have potential as a biomarker for gastrointestinal disorders.

95 sorders (ASD) predominantly in patients with gastrointestinal disorders.

96 uctions in quality of life and reported more gastrointestinal doctor consultations than other subject

97 For proof of concept, we select the gastrointestinal drug metabolic enzyme NAT2 at 8p22, whi

98 re neglected tropical diseases caused by the gastrointestinal dwelling nematodes Trichuris trichiura

99 mary of metabolites modestly associated with gastrointestinal dysfunction in ASD is provided, and a p

100 metabolic imbalances, immune dysregulation, gastrointestinal dysfunction, and altered gut microbiome

101 oing radiotherapy, who also displayed milder gastrointestinal dysfunction.

102 al tract caused by allergic inflammation and gastrointestinal dysfunction.

103 e children that were electively admitted for gastrointestinal endoscopies were included.

104 Gastrointestinal endoscopy may be associated with pain a

105 iagnosis studies using DESI-MSI in the upper gastrointestinal endoscopy suite, as well as functional

106 the oral route remains poor due to the harsh gastrointestinal environment.

107 The primary end point was the change in gastrointestinal eosinophil count from baseline to 2 wee

108 The mean percentage change in gastrointestinal eosinophil count was -86% in the combin

109 ads to severe inflammation and damage to the gastrointestinal epithelium due to the production of pot

110 has a tuft cell restricted expression in the gastrointestinal epithelium.

111 itated the release of bioactive compounds to gastrointestinal fluid.

112 h system simulates digestion by transferring gastrointestinal fluids and digestive secretions at phys

113 ther investigation of mechanisms involved in gastrointestinal function, repair and regeneration.

114 Spanish, and had recently diagnosed breast, gastrointestinal, genitourinary, gynecological, head and

115 ines are widely used in the modelling of the gastrointestinal (GI) absorption of drugs and in oral dr

116 ved lipid hormones that fundamentally impact gastrointestinal (GI) biology.

117 A sequencing in 1,687 patients with advanced gastrointestinal (GI) cancer in SCRUM-Japan GOZILA (no.

118 ggests a link between household fuel use and gastrointestinal (GI) cancers.

119 ta/Delta mutants showed reduced fitness in a gastrointestinal (GI) colonization model, yet induced gr

120 Gastrointestinal (GI) colonization with group B Streptoc

121 study aimed to analyze the effect of elderly gastrointestinal (GI) conditions on proteolysis, lipolys

122 processes that maintain the function of the gastrointestinal (GI) epithelium are critical for health

123 SHP2 is involved in gastrointestinal (GI) epithelium development and homeost

124 unknown despite reports of taste changes in gastrointestinal (GI) inflammatory conditions.

125 bial diversity differing substantially among gastrointestinal (GI) locations.

126 ed as a primary interoceptive cortex, during gastrointestinal (GI) malaise, a state akin to the emoti

127 Gastrointestinal (GI) pain - a form of visceral pain - i

128 inferred function, fecal SCFA concentration, gastrointestinal (GI) symptoms, dietary intake, and qual

129 The gastrointestinal (GI) tract (GIT) holds significant pote

130 th disease initiation and progression in the gastrointestinal (GI) tract and associated organs.

131 matory toxicities, many of which involve the gastrointestinal (GI) tract and liver.

132 otope-specific water-metabolism in the human gastrointestinal (GI) tract and respiratory system are l

133 the signaling pathways mutation rate in the Gastrointestinal (GI) tract cancers in a systematic revi

134 The application of NIR-II emitters for gastrointestinal (GI) tract imaging remains challenging

135 but its effectiveness is severely limited by gastrointestinal (GI) tract toxicity caused by gut bacte

136 isorder characterized by inflammation of the gastrointestinal (GI) tract, and it is associated with d

137 he formation of microbial communities in the gastrointestinal (GI) tract.

138 ure used for the treatment of lesions in the gastrointestinal (GI) tract.

139 also been implicated in the pathogenesis of gastrointestinal (GI)-related cancers, including gastric

140 e impacts of NA-chelated Fe on Fe status and gastrointestinal health when delivered to chickens throu

141 Therefore, we used the gastrointestinal helminth pathogen Trichuris muris to te

142 We present a rare case of primary gastrointestinal histoplasmosis manifesting with acute g

143 ling plays important roles in embryogenesis, gastrointestinal homeostasis, and food intake.

144 oV-2) infection detected by lung, brain, and gastrointestinal imaging may confound radiologists' inte

145 ly manifests as a short-lived, self-limiting gastrointestinal infection in humans, however prolonged

146 chronic systemic inflammatory response to a gastrointestinal infection would similarly affect CNS pr

147 ncluding bacteria that do not normally cause gastrointestinal infections.

148 rate elevations in risks for skin cancer and gastrointestinal, infectious, pulmonary, and hematologic

149 impact of HTST and HoP pasteurization on the gastrointestinal kinetics of human milk, using a dynamic

150 and vomiting and no signs of severe ileus or gastrointestinal luminal obstruction.

151 ndrome with dermatologic, mucocutaneous, and gastrointestinal manifestations was associated with card

152 ght to assess the predictive capacity of the gastrointestinal microbiome and its relationship to infe

153 -sectional cohorts explored suggest that the gastrointestinal microbiome may exert immunomodulatory e

154 Gastrointestinal microbiota and immune cells interact cl

155 isolate blend, was evaluated in an in vitro gastrointestinal model.

156 stion in simulated conditions using in vitro gastrointestinal models.

157 to play important roles in the regulation of gastrointestinal motility and secretion, appetite, and f

158 ion, visceral hypersensitivity, and abnormal gastrointestinal motility.

159 are rapidly depleted from the periphery and gastrointestinal mucosa during acute HIV-1 infection.

160 ockade involve either barrier tissues (e.g., gastrointestinal mucosa or skin) or endocrine organs, al

161 w lentiviral infection perturbs the oral and gastrointestinal mucosae of infant macaques through alte

162 astritis and duodenitis are characterized by gastrointestinal mucosal eosinophilia, chronic symptoms,

163 of study included clinical cancer (n = 43), gastrointestinal (n = 13), cardiothoracic/vascular (n =

164 index is an established prognostic factor in gastrointestinal neuroendocrine tumors (GI-NETs) and def

165 rtical body-to-brain neural pathways linking gastrointestinal nutrient sensors to the brain's reward

166 The ex vivo generation of gastrointestinal organoids from crypt stem cells opens u

167 We analyzed the clinical features and gastrointestinal outcomes of patients with FPIES retrosp

168 Giardia duodenalis is a major gastrointestinal parasite of humans and animals across t

169 Using sex-specific blood and gastrointestinal parasite prevalence from 96 and 54 avia

170 sing approach for reducing cell death during gastrointestinal passage and controlling the release of

171 t to the transmission of multidrug-resistant gastrointestinal pathogens and the risk of treatment fai

172 ogy Reports in Sweden) study, which included gastrointestinal pathology reports from all of Sweden's

173 through differences in appetite sensations, gastrointestinal peptide release and food intake, but th

174 tion of gastrointestinal tract, diagnosis of gastrointestinal peristalsis disorder and NIR-II FI-guid

175 n GI tract, and migrated homogenously during gastrointestinal peristalsis to allow visualization of t

176 pendently associated with death, whereas the gastrointestinal phenotype was associated with recovery.

177 the dysregulation of host cells and altered gastrointestinal physiology to cause diarrhea.

178 ngs support a connection between metabolism, gastrointestinal physiology, and complex behavioral trai

179 Our results demonstrate that off-target gastrointestinal populations rapidly respond to intraven

180 Cannabis and its derivatives affect many gastrointestinal processes via the endocannabinoid syste

181 QoL at 5-year follow-up, as measured by the Gastrointestinal Quality of Life Index (GIQLI).

182 f ICC-IM mediating neural responses in other gastrointestinal regions.

183 rogressively raised the attention toward the gastrointestinal, renal, and cardiovascular toxicity.

184 stradiation restoration of hematopoiesis and gastrointestinal repair.

185 leptin, acting in the NTS, could potentiate gastrointestinal satiation signals.

186 he aim of this study was to use barium upper gastrointestinal series (UGI) to evaluate the developmen

187 pneumonia, antibiotic use, or respiratory or gastrointestinal signs; history in the past 24 h of diff

188 ignificantly different GMB communities: both gastrointestinal sites were dominated by Firmicutes and

189 sea and other gastrointestinal symptoms, non-gastrointestinal somatic symptoms, and psychological dys

190 Gastrointestinal stromal tumor (GIST) is the most common

191 y data, and evolving knowledge regarding the gastrointestinal stromal tumour treatment paradigm, it w

192 ble safety profile in patients with advanced gastrointestinal stromal tumours who were resistant to a

193 nal involvement in adenocarcinoma, lymphoma, gastrointestinal stromal tumours, Crohn's disease, and g

194 he study included patients with unresectable gastrointestinal stromal tumours.

195 n patients with previously treated, advanced gastrointestinal stromal tumours.

196 ients undergoing elective or emergency major gastrointestinal surgery from September to December 2015

197 is safe in selected patients following major gastrointestinal surgery.

198 This did not result in gastrointestinal symptomatology or have any significant

199 Nemolizumab was associated with gastrointestinal symptoms (abdominal pain and diarrhea)

200 in adults, the pediatric model also included gastrointestinal symptoms (inverse association), and the

201 MNGIE mainly presents with gastrointestinal symptoms and is mostly misdiagnosed in

202 The impact of esophagectomy on gastrointestinal symptoms and long-term HRQOL should be

203 recurrence), the presence and recurrence of gastrointestinal symptoms and the length of hospital sta

204 Carbohydrate malabsorption and subsequent gastrointestinal symptoms are a common clinical problem

205 Persistent fever and gastrointestinal symptoms are the most common symptoms.

206 t tolerated oral miltefosine well, with mild gastrointestinal symptoms as the most common systemic si

207 associated with decreased HRQOL and lasting gastrointestinal symptoms up to 20 years after surgery.

208 Gastrointestinal symptoms were more common with folic ac

209 Gastrointestinal symptoms were prominent.

210 ever or chills; 97% had tachycardia, 80% had gastrointestinal symptoms, 60% had rash, 56% had conjunc

211 associated with a wide variety of individual gastrointestinal symptoms, as well as headaches, fatigue

212 ute coronary syndromes, acute kidney injury, gastrointestinal symptoms, hepatocellular injury, hyperg

213 ssess relationships between nausea and other gastrointestinal symptoms, non-gastrointestinal somatic

214 Secondary outcomes were gastrointestinal symptoms, waist circumference, glycemic

215 rCDI (n = 31), as well as the development of gastrointestinal symptoms, were assessed.

216 ossible COVID-19 in patients presenting with gastrointestinal symptoms.

217 sociated with decreased HRQOL and persistent gastrointestinal symptoms.

218 ool specimens (n = 79) from 77 patients with gastrointestinal symptoms.

219 eady been demonstrated by cardiovascular and gastrointestinal symptoms.

220 d 20% of patients with COVID-19 present with gastrointestinal symptoms.

221 ents with SEP-363856 included somnolence and gastrointestinal symptoms; one sudden cardiac death occu

222 dose TAI-FLASH produced less mortality from gastrointestinal syndrome, spared gut function and epith

223 Gastrointestinal system (GIS) malignancy with pregnancy

224 Gastrointestinal system (GIS) malignancy with pregnancy

225 introducing the device into the animal upper gastrointestinal system and performing in vivo analyses

226 Organ-system involvement included the gastrointestinal system in 171 patients (92%), cardiovas

227 ; PM10, 1.457 [1.150, 1.846; p = 0.002]) and gastrointestinal systems (NO2, 1.214 [1.006, 1.466; p =

228 ase (JAK) inhibitors that selectively target gastrointestinal tissues with limited systemic exposures

229 sted in this disease with the aim to improve gastrointestinal tolerability.

230 Also, higher antioxidant activities in gastrointestinal track model system was found for SPC-CH

231 IgA response in the FRT relies on the FRT to gastrointestinal tract (GIT) antigen transport.

232 perties of ingested nanoparticles within the gastrointestinal tract (GIT) is critical for evaluating

233 ized by a massive loss of CD4 T cells in the gastrointestinal tract (GIT) that is accompanied by chan

234 ed to coat CTX to facilitate delivery to the gastrointestinal tract (GIT).

235 rt intestinal immunity to persist within the gastrointestinal tract (GIT); yet, the underlying mechan

236 is for primary malignancies within the lower gastrointestinal tract (LGT).

237 of physiological processes, both within the gastrointestinal tract and at distant tissue sites.

238 l2), which is predominantly expressed in the gastrointestinal tract and downregulated in human colon

239 EGIDs can affect other parts of the gastrointestinal tract and include eosinophilic gastriti

240 e importance of considering polyposis of the gastrointestinal tract and low grade neuroendocrine tumo

241 The lamina propria of the gastrointestinal tract and other mucosal surfaces of hum

242 me coronavirus-2 is capable of infecting the gastrointestinal tract and shedding in the environment f

243 ropheryma whipplei occurs classically in the gastrointestinal tract and shows histopathologically foa

244 lating agents that are prevalent in the host gastrointestinal tract and which are substrates of the V

245 e that exposure to microbial amyloids in the gastrointestinal tract can accelerate alphaSyn aggregati

246 al diseases (EGIDs) are rare diseases of the gastrointestinal tract caused by allergic inflammation a

247 dea in a mouse model of Enterococcus faecium gastrointestinal tract colonization.

248 Inflammation of the gastrointestinal tract contributes to the development of

249 d expression of AHR in neurons of the distal gastrointestinal tract enables these neurons to respond

250 Each day, the gastrointestinal tract encounters an influx of microbial

251 d the main ways to acquire the pathogen, the gastrointestinal tract is believed to be an underreporte

252 The human gastrointestinal tract is home to a vibrant, diverse eco

253 de, nucleic acids) also translocate from the gastrointestinal tract lumen.

254 ade 2 acute GVHD with isolated skin or upper gastrointestinal tract manifestations; fluticasone, azit

255 ) explored by Chlamydia for spreading to the gastrointestinal tract may promote our understanding of

256 icrobial genomes in an ecosystem such as the gastrointestinal tract of a human.

257 he intestinal microbiota, resides within the gastrointestinal tract of animals and plays a role in ma

258 Environmental isolates readily colonize the gastrointestinal tract of humans and other animals, and

259 sfunctions is neobladder reconstruction with gastrointestinal tract segments.

260 osalpinx with chlamydial colonization in the gastrointestinal tract than in the genital tract.

261 esident oral bacteria can translocate to the gastrointestinal tract through hematogenous and enteral

262 Bile salts are secreted into the gastrointestinal tract to aid in the absorption of lipid

263 ed PLJ was not chemically transformed during gastrointestinal tract transit.

264 n microbiome and biochemical activity in the gastrointestinal tract upon ingestion.

265 ital Chlamydia is able to both spread to the gastrointestinal tract via an FTY720-resistant pathway a

266 The gastrointestinal tract was found to be a site for low-le

267 itamin D receptor is highly expressed in the gastrointestinal tract where it transacts gene expressio

268 spreads from the mouse genital tract to the gastrointestinal tract while inducing oviduct fibrotic b

269 After gastrointestinal tract, all beverages showed an increase

270 kin (61.1%), upper (45.5%) and lower (46.0%) gastrointestinal tract, and liver (26.7%).

271 ular system, kidney, central nervous system, gastrointestinal tract, and skin, among others.

272 , anaerobic bacterium that infects the human gastrointestinal tract, causing a wide range of disorder

273 high sensitivity real-time visualization of gastrointestinal tract, diagnosis of gastrointestinal pe

274 m between the central nervous system and the gastrointestinal tract, especially during developmental

275 tract also reduce their colonization in the gastrointestinal tract, leading to a better correlation

276 xpressed in the human body, including in the gastrointestinal tract, platelets and the nervous system

277 t T-cell lymphoproliferative disorder of the gastrointestinal tract, the patient received steroid the

278 microbial molecules that are produced in the gastrointestinal tract, which can subsequently permeate

279 TS) is activated by vagal afferents from the gastrointestinal tract, which promotes termination of a

280 urs via diet-derived nitrating agents in the gastrointestinal tract.

281 dia produced infectious progenies throughout gastrointestinal tract.

282 (mouse Fam3D), is highly expressed in mouse gastrointestinal tract.

283 e is the resident microbial community of the gastrointestinal tract.

284 and the volume reduction of the food in the gastrointestinal tract.

285 most common human sarcoma and arises in the gastrointestinal tract.

286 ing Bacteroidales that inhabit the mammalian gastrointestinal tract.

287 ceptible to environmental conditions and the gastrointestinal tract.

288 ter endoscopic biopsy samples from the human gastrointestinal tract.

289 e contrast for early cancer detection in the gastrointestinal tract.

290 lamydial colonization in distinct regions of gastrointestinal tract.

291 hronic immune-mediated disease affecting the gastrointestinal tract.

292 including the oral cavity, the skin, and the gastrointestinal tract.

293 hat ensures the intrinsic innervation of the gastrointestinal tract.

294 NS) as well as enterochromaffin cells of the gastrointestinal tract.

295 l tracts, is also frequently detected in the gastrointestinal tract.

296 otypes of Escherichia coli isolated from the gastrointestinal tracts of European starlings (Sturnus v

297 o has a dual tropism for the respiratory and gastrointestinal tracts.

298 slowed colonic motility, and prolonged total gastrointestinal transit.

299 tients undergoing elective colorectal, upper gastrointestinal, transplant, or hepatopancreaticobiliar

300 cough (66%), dyspnea (50%), fever (47%), and gastrointestinal upset (44%).